Home
>
National Drug Code (NDC)
>
Pentoxifylline
Pentoxifylline - 0093-5116-05 - (Pentoxifylline)
Drug Information of Pentoxifylline
| Product NDC: | 0093-5116 |
| Proprietary Name: | Pentoxifylline |
| Non Proprietary Name: | Pentoxifylline |
| Active Ingredient(s): | 400 mg/1 & nbsp; Pentoxifylline |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Pentoxifylline
| Product NDC: | 0093-5116 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075028 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19980731 |
Package Information of Pentoxifylline
| Package NDC: | 0093-5116-05 |
| Package Description: | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0093-5116-05) |
NDC Information of Pentoxifylline
| NDC Code | 0093-5116-05 |
| Proprietary Name | Pentoxifylline |
| Package Description | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0093-5116-05) |
| Product NDC | 0093-5116 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Pentoxifylline |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19980731 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | PENTOXIFYLLINE |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] |
